Avid Bioservices Inc

Company Profile

Avid Bioservices Inc had its IPO on 2018-01-08 under the ticker symbol CDMO.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Avid Bioservices Inc has a staff strength of 0 employees.

Stock update

Shares of Avid Bioservices Inc opened at $15.67 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $15.15 - $16.17, and closed at $15.23.

This is a -3.3% slip from the previous day's closing price.

A total volume of 411,276 shares were traded at the close of the day’s session.

In the last one week, shares of Avid Bioservices Inc have slipped by -10.41%.

Avid Bioservices Inc's Key Ratios

Avid Bioservices Inc has a market cap of $0.947 billion, indicating a price to book ratio of 5.47 and a price to sales ratio of 7.54.

In the last 12-months Avid Bioservices Inc’s revenue was $0.126 billion with a gross profit of $0.037 billion and an EBITDA of $0.016 billion. The EBITDA ratio measures Avid Bioservices Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Avid Bioservices Inc’s operating margin was 8.94% while its return on assets stood at 1.94% with a return of equity of 109.9%.

In Q2.3333333333333, Avid Bioservices Inc’s quarterly earnings growth was a negative -80% while revenue growth was a positive 19.3%.

Avid Bioservices Inc’s PE and PEG Ratio

Forward PE

196.08

Trailing PE

9.07

PEG

None

Its diluted EPS in the last 12-months stands at $1.68 per share while it has a forward price to earnings multiple of 196.08 and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Avid Bioservices Inc’s profitability.

Avid Bioservices Inc stock is trading at a EV to sales ratio of 8.33 and a EV to EBITDA ratio of 64.65. Its price to sales ratio in the trailing 12-months stood at 7.54.

Avid Bioservices Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Avid Bioservices Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Avid Bioservices Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Avid Bioservices Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Avid Bioservices Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Avid Bioservices Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$15.23

52-Week High

$34.51

52-Week Low

$11.3

Analyst Target Price

$26

Avid Bioservices Inc stock is currently trading at $15.23 per share. It touched a 52-week high of $34.51 and a 52-week low of $34.51. Analysts tracking the stock have a 12-month average target price of $26.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.